advanced solid tumors
Showing 1 - 25 of 533
Advanced Solid Tumors Trial in Guangzhou (MR001)
Not yet recruiting
- Advanced Solid Tumors
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Nov 12, 2023
Advanced Solid Tumors Trial (SHR-A2009 for injection ; Almonertinib Mesilate Tablets, SHR-A2009 for injection;Adebrelimab
Not yet recruiting
- Advanced Solid Tumors
- SHR-A2009 for injection ; Almonertinib Mesilate Tablets
- SHR-A2009 for injection;Adebrelimab Injection
- (no location specified)
Oct 17, 2023
Advanced Solid Tumors Trial (c610 injection)
Not yet recruiting
- Advanced Solid Tumors
- c610 injection
- (no location specified)
Oct 7, 2023
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
San Antonio, Texas
- +1 more
Sep 8, 2023
Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)
Not yet recruiting
- Advanced Solid Tumors
- B-cell Non-Hodgkin Lymphomas
- (no location specified)
Aug 31, 2023
Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986466
- +2 more
-
Birmingham, Alabama
- +24 more
Aug 29, 2023
Advanced Solid Tumors Trial (KN510 60mg/day + KN713 60mg/day, KN510 120mg/day + KN713 60mg/day, KN510 120mg/day + KN713
Not yet recruiting
- Advanced Solid Tumors
- KN510 60mg/day + KN713 60mg/day
- +3 more
- (no location specified)
Aug 24, 2023
Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))
Recruiting
- Advanced Solid Tumors
- Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
-
Hangzhou, ChinaFirst affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023
Advanced Solid Tumors Trial (AK127 in combination with AK112)
Not yet recruiting
- Advanced Solid Tumors
- AK127 in combination with AK112
- (no location specified)
Jul 11, 2023
Advanced Solid Tumors Trial in China (SPH4336, Cadonilimab)
Not yet recruiting
- Advanced Solid Tumors
-
Fuzhou, Fujian, China
- +15 more
Jul 12, 2023
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Advanced Solid Tumors Trial in Shanghai (HRXG-K-1939, Adebrelimab)
Not yet recruiting
- Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 4, 2023
Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)
Not yet recruiting
- Advanced Solid Tumors
- Recombinant human IL-21 oncolytic vaccinia virus injection
-
Hangzhou, Zhejiang, China
- +1 more
Jun 21, 2023
Advanced Solid Tumors Trial in Plantation (DB-1311)
Not yet recruiting
- Advanced Solid Tumors
-
Plantation, FloridaBRCR Medical Center Inc.
Jun 13, 2023